PDCD1 and cancer: For example, cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and the programmed cell death protein 1 pathway (PD-1/PD-L1) checkpoint inhibitors are currently arising as a novel strategy to fight cancer, including GBM.